Stock AGN ALLERGAN PLC
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Allergan plc

Equities

AGN

IE00BY9D5467

Delayed Nyse
Other stock markets
 		5-day change 1st Jan Change
- USD -.--% Intraday chart for Allergan plc +1.73% +0.97%
03-05 Allergan Aesthetics Announces the U.S. FDA Approval of JUVEDERM VOLUMA XC for Injection in the Temple Region to Improve Moderate to Severe Temple Hollowing in Adults over the Age of 21 CI
2023 Allergan Aesthetics Announces Positive Topline Results from Second Phase 3 Study of Onabotulinumtoxina for the Treatment of Platysma Prominence CI
a42a8e5379f478e705304fa4780.2lzDVhASQCwzs4lw1Wmc1hSFYXl6-S8ULlpBPyAlyBI.jm6HM3leFBhb6uhdigv1iWHXJU8jnRZzGQ4JaWQVrUuWLKF7anshWF7i5g~8c904966afdf12d845b2dc2a13c30bff
  1. Stock Market
  2. Equities
  3. AGN Stock
  4. Charts Allergan plc
  5. News Chart